**Core Concept**
Physostigmine and bethanechol are both cholinomimetic agents that mimic the action of acetylcholine, a neurotransmitter involved in the parasympathetic nervous system. However, they differ in their mechanism of action and the specific receptors they interact with.

**Why the Correct Answer is Right**
Physostigmine is an acetylcholinesterase inhibitor, which means it prevents the breakdown of acetylcholine in the synaptic cleft, thereby increasing the concentration of acetylcholine available for binding to muscarinic and nicotinic receptors. In contrast, bethanechol is a direct-acting muscarinic receptor agonist that directly stimulates muscarinic receptors. The key difference between the two lies in their effect on the neuromuscular junction, where nicotinic receptors are present. Physostigmine's inhibition of acetylcholinesterase allows for increased nicotinic receptor stimulation, leading to increased muscle contraction and fasciculations, whereas bethanechol's direct muscarinic receptor stimulation does not have a significant effect on the neuromuscular junction.

**Why Each Wrong Option is Incorrect**
**Option A:** Gastric secretion - While both physostigmine and bethanechol can stimulate gastric secretion through muscarinic receptor activation, this is not the primary difference between them at therapeutic doses.
**Option C:** Sweat glands - Both agents can stimulate sweat glands through muscarinic receptor activation, but this is not the key difference between them.
**Option D:** Ureteral tone - Both agents can increase ureteral tone through muscarinic receptor activation, but this is not the primary difference between them.

**Clinical Pearl / High-Yield Fact**
When using cholinomimetic agents, it's essential to consider their mechanism of action and potential effects on the neuromuscular junction, as this can lead to increased muscle contraction and fasciculations.

**✓ Correct Answer: B. Neuromuscular junction**